TNF and cardiomyopathy: It is already established that elevation in inflammatory mediators in the heart is associated with cardiac dysfunction [26], but it has been contentious as to whether TNF-α mediates inflammation and fibrosis in doxorubicin-induced cardiomyopathy and the failing heart [27]–[30].